- Home
- SNBR vs OLMA Comparison
SNBR vs OLMA Comparison
Compare SNBR & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNBR | OLMA |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 725.5M |
| IPO Year | 1998 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNBR | OLMA |
|---|---|---|
| Price | $8.46 | $33.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $8.00 | ★ $40.50 |
| AVG Volume (30 Days) | 891.0K | ★ 8.5M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,440,882,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.49 | $2.86 |
| 52 Week High | $20.73 | $33.50 |
Technical Indicators
Market Signals| Indicator | SNBR | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 75.78 | 82.93 |
| Support Level | $3.81 | $25.62 |
| Resistance Level | $7.86 | $33.50 |
| Average True Range (ATR) | 0.70 | 2.25 |
| MACD | 0.42 | 0.27 |
| Stochastic Oscillator | 99.48 | 96.91 |
Price Performance
Historical ComparisonAbout SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.